AbbVie (NYSE:ABBV) just scored a big win for its next-generation arthritis drug. The company said Monday that Rinvoq ...

Discover Merck & Co., Inc.'s Q3 earnings outlook as Keytruda's patent nears expiry. Click for my updated look at MRK stock ...

With $70 million and a phase 2 ready asset in hand, British biotech Elevara Medicines has emerged to try to revolutionize the ...

The stock's forward yield of 2.8% is higher than the S&P 500 's average of 1.2%, and its cash payout ratio of 61.8% is ...

In a first, Colorado will cap the price of Enbrel, an arthritis drug. Using patent tactics, the drugmaker Amgen has ...

Stocks rose to begin a busy week that will see a flurry of corporate earnings reports, with investors also awaiting further ...

The North Carolina State Health Plan experience shows us that large, self-insured employers can work to bend the cost curve ...

A young woman shares her emotional 15-year journey with hidradenitis suppurativa, chronic skin inflammation for which ...

Detailed price information for Meta Platforms Inc (META-Q) from The Globe and Mail including charting and trades.

In an unpredictable market that shifts between greed and fear, income investors who own Dividend Kings sleep better at night, ...

Opioids were once the go-to solution for surgical pain relief, but unwanted side effects like nausea, dizziness, constipation ...

Although lowering drug costs is one of the few issues uniting almost all Americans, the president has done little to ...